Subsequently, Transwell assay results suggested that downregulated CCDC183-AS1 attenuated cell migration (Figures 2(f) and 2(g)) and invasion (Figures 2(h) and 2(i)), indicating that CCDC183-AS1 might function as an oncogene role in BC development. The gene discussed is CCDC183; the disease is breast cancer.